Cargando…
Agonism and Antagonism at the Insulin Receptor
Insulin can trigger metabolic as well as mitogenic effects, the latter being pharmaceutically undesirable. An understanding of the structure/function relationships between insulin receptor (IR) binding and mitogenic/metabolic signalling would greatly facilitate the preclinical development of new ins...
Autores principales: | Knudsen, Louise, Hansen, Bo Falck, Jensen, Pia, Pedersen, Thomas Åskov, Vestergaard, Kirsten, Schäffer, Lauge, Blagoev, Blagoy, Oleksiewicz, Martin B., Kiselyov, Vladislav V., De Meyts, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531387/ https://www.ncbi.nlm.nih.gov/pubmed/23300584 http://dx.doi.org/10.1371/journal.pone.0051972 |
Ejemplares similares
-
Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation
por: Kiselyov, Vladislav V, et al.
Publicado: (2009) -
The future of EPAC-targeted therapies: agonism versus antagonism
por: Parnell, Euan, et al.
Publicado: (2015) -
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
por: Campbell, Jonathan E.
Publicado: (2020) -
Synchronization in G(0)/G(1) enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin
por: Bonnesen, Christine, et al.
Publicado: (2009) -
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
por: Singhal, Hari, et al.
Publicado: (2016)